Study Proposal - A Randomized Double-Blinded Study Comparing Adding Etoricoxib Versus Placebo to Female Patients With Fibromyalgia-Analysis of Organic and Psychiatric Measures.

Trial Profile

Study Proposal - A Randomized Double-Blinded Study Comparing Adding Etoricoxib Versus Placebo to Female Patients With Fibromyalgia-Analysis of Organic and Psychiatric Measures.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Etoricoxib (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jan 2016 Status changed from recruiting to completed according to results published in the International Journal of Clinical Practice.
    • 13 Jan 2016 Primary endpoint of brief pain inventory has not been met, according to results published in the International Journal of Clinical Practice.
    • 13 Jan 2016 Results published in the International Journal of Clinical Practice
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top